{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:21:52Z","timestamp":1777584112688,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00467-023-05912-2","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T08:03:55Z","timestamp":1679299435000},"page":"3083-3090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperkalemia in pediatric chronic kidney disease"],"prefix":"10.1007","volume":"38","author":[{"given":"Katherine L","family":"Kurzinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek K","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L","family":"Furth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-6587","authenticated-orcid":false,"given":"Bradley A","family":"Warady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the CKiD Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"5912_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s40265-021-01555-5","volume":"81","author":"JM Valdivielso","year":"2021","unstructured":"Valdivielso JM, Balafa O, Ekart R, Ferro C et al (2021) Hyperkalemia in chronic kidney disease in the new era of kidney protection therapies. Drugs 81:1467\u20131489. https:\/\/doi.org\/10.1007\/s40265-021-01555-5","journal-title":"Drugs"},{"key":"5912_CR2","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2215\/CJN.00580118","volume":"13","author":"CF Whittaker","year":"2018","unstructured":"Whittaker CF, Miklich MA, Patel RS, Fink JC (2018) Medication safety principles and practice in CKD. Clin J Am Soc Nephrol 13:1738\u20131746. https:\/\/doi.org\/10.2215\/CJN.00580118","journal-title":"Clin J Am Soc Nephrol"},{"key":"5912_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ackd.2017.06.004","volume":"24","author":"S Gilligan","year":"2017","unstructured":"Gilligan S, Raphael KL (2017) Hyperkalemia and hypokalemia in CKD: prevalence, risk factors, and clinical outcomes. Adv Chronic Kidney Dis 24:315\u2013318. https:\/\/doi.org\/10.1053\/j.ackd.2017.06.004","journal-title":"Adv Chronic Kidney Dis"},{"key":"5912_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2215\/CJN.01730215","volume":"11","author":"J Luo","year":"2016","unstructured":"Luo J, Brunelli SM, Jensen DE, Yang A (2016) Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol 11:90\u2013100. https:\/\/doi.org\/10.2215\/CJN.01730215","journal-title":"Clin J Am Soc Nephrol"},{"key":"5912_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000437151","volume":"41","author":"GN Nakhoul","year":"2015","unstructured":"Nakhoul GN, Huang H, Arrigain S, Jolly S et al (2015) Serum potassium, end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol 41:456\u2013463. https:\/\/doi.org\/10.1159\/000437151","journal-title":"Am J Nephrol"},{"key":"5912_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/j.ackd.2017.06.002","volume":"24","author":"TD DuBose","year":"2017","unstructured":"DuBose TD (2017) Regulation of potassium homeostasis in CKD. Adv Chronic Kidney Dis 24:305\u2013314. https:\/\/doi.org\/10.1053\/j.ackd.2017.06.002","journal-title":"Adv Chronic Kidney Dis"},{"key":"5912_CR7","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00467-020-04788-w","volume":"36","author":"E Chan","year":"2021","unstructured":"Chan E, Ma A, Tullus K (2021) When should we start and stop ACEi\/ARB in paediatric chronic kidney disease? Pediatr Nephrol 36:1751\u20131764. https:\/\/doi.org\/10.1007\/s00467-020-04788-w","journal-title":"Pediatr Nephrol"},{"key":"5912_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2215\/CJN.09750819","volume":"15","author":"SM van den Belt","year":"2020","unstructured":"van den Belt SM, Heerspink HJL, Kirchner M, Gracchi V et al (2020) Discontinuation of RAAS inhibition in children with advanced CKD. Clin J Am Soc Nephrol 15:625\u2013632. https:\/\/doi.org\/10.2215\/CJN.09750819","journal-title":"Clin J Am Soc Nephrol"},{"key":"5912_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00467-016-3512-4","volume":"32","author":"AG Abraham","year":"2017","unstructured":"Abraham AG, Betoko A, Fadrowski JJ, Pierce C et al (2017) Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Pediatr Nephrol 32:643\u2013649. https:\/\/doi.org\/10.1007\/s00467-016-3512-4","journal-title":"Pediatr Nephrol"},{"key":"5912_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.ki.5001608","volume":"70","author":"H Wong","year":"2006","unstructured":"Wong H, Mylrea K, Feber J, Drukker A, Filler G (2006) Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70:585\u2013590. https:\/\/doi.org\/10.1038\/sj.ki.5001608","journal-title":"Kidney Int"},{"key":"5912_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2215\/CJN.01941205","volume":"1","author":"SL Furth","year":"2006","unstructured":"Furth SL, Cole SR, Moxey-Mims M, Kaskel F et al (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006\u20131015. https:\/\/doi.org\/10.2215\/CJN.01941205","journal-title":"Clin J Am Soc Nephrol"},{"key":"5912_CR12","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Mu\u00f1oz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956. https:\/\/doi.org\/10.1016\/j.kint.2020.10.047","journal-title":"Kidney Int"},{"issue":"2 Suppl 1","key":"5912_CR13","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-266","journal-title":"Am J Kidney Dis"},{"key":"5912_CR14","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.kint.2017.05.006","volume":"92","author":"J Harambat","year":"2017","unstructured":"Harambat J, Kunzmann K, Azukaitis K, Bayazit A et al (2017) Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease. Kidney Int 92:1507\u20131514. https:\/\/doi.org\/10.1016\/j.kint.2017.05.006","journal-title":"Kidney Int"},{"key":"5912_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2215\/CJN.07060619","volume":"15","author":"DD Brown","year":"2020","unstructured":"Brown DD, Roem J, Ng DK, Reidy K et al (2020) Low serum bicarbonate and CKD progression in children. Clin J Am Soc Nephrol 15:755\u2013765. https:\/\/doi.org\/10.2215\/CJN.07060619","journal-title":"Clin J Am Soc Nephrol"},{"key":"5912_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.34067\/KID.0005402021","volume":"3","author":"DD Brown","year":"2022","unstructured":"Brown DD, Carroll M, Ng DK, Levy R et al (2022) Longitudinal associations between low serum bicarbonate and linear growth in children with CKD. Kidney360 3:666\u2013676. https:\/\/doi.org\/10.34067\/KID.0005402021","journal-title":"Kidney360"},{"key":"5912_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1159\/000475997","volume":"45","author":"T Kim","year":"2017","unstructured":"Kim T, Rhee CM, Streja E, Soohoo M et al (2017) Racial and ethnic differences in mortality associated with serum potassium in a large hemodialysis cohort. Am J Nephrol 45:509\u2013521. https:\/\/doi.org\/10.1159\/000475997","journal-title":"Am J Nephrol"},{"key":"5912_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000502998","volume":"50","author":"R Eriguchi","year":"2019","unstructured":"Eriguchi R, Obi Y, Soohoo M, Rhee C et al (2019) Racial and ethnic differences in mortality associated with serum potassium in incident peritoneal dialysis patients. Am J Nephrol 50:361\u2013369. https:\/\/doi.org\/10.1159\/000502998","journal-title":"Am J Nephrol"},{"key":"5912_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.ajkd.2022.01.002","volume":"80","author":"SJ Leon","year":"2022","unstructured":"Leon SJ, Whitlock R, Rigatto C, Komenda P et al (2022) Hyperkalemia-related discontinuation of renin-angiotensin-aldosterone system inhibitors and clinical outcomes in CKD: a population-based cohort study. Am J Kidney Dis 80:164-173.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2022.01.002","journal-title":"Am J Kidney Dis"},{"key":"5912_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.ajkd.2022.02.012","volume":"80","author":"BF Palmer","year":"2022","unstructured":"Palmer BF, Clegg DJ (2022) Managing hyperkalemia to enable guideline-recommended dosing of renin-angiotensin-aldosterone system inhibitors. Am J Kidney Dis 80:158\u2013160. https:\/\/doi.org\/10.1053\/j.ajkd.2022.02.012","journal-title":"Am J Kidney Dis"},{"key":"5912_CR21","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.ajkd.2008.11.017","volume":"53","author":"National Kidney Foundation","year":"2009","unstructured":"National Kidney Foundation (2009) KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Am J Kidney Dis 53:S11\u2013S104. https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.017","journal-title":"Am J Kidney Dis"},{"key":"5912_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00467-021-04923-1","volume":"36","author":"A Desloovere","year":"2021","unstructured":"Desloovere A, Renken-Terhaerdt J, Tuokkola J, Shaw V et al (2021) The dietary management of potassium in children with CKD stages 2\u20135 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol 36:1331\u20131346. https:\/\/doi.org\/10.1007\/s00467-021-04923-1","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-05912-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T07:03:24Z","timestamp":1692169404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-05912-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5912"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-05912-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CKiD protocols and sites were approved by local site Institutional Review Boards (IRBs) and informed consent and assent were provided by all parents and appropriately-aged participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\/IRB approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}